Supply Chain

Americans will spend more than $18 billion on Valentine's Day gifts in 2017, according to the National Retail Federation.

Sen. Chuck Grassley, R-Iowa, launched an inquiry into whether a loophole in the Orphan Drug Act could have contributed to high drug costs for many common medications, reports Kaiser Health News.

Marathon Pharmaceuticals' newly approved steroid deflazacort will have a list price of $89,000 a year, reports The Washington Post.

Paris-based drugmaker Ipsen will purchase five over-the-counter treatments from its rival Sanofi for 83 million euros, or $88 million, reports Reuters.

New Haven, Conn.-based Yale University and Rochester, Minn.-based Mayo Clinic are establishing a Center for Excellence in Regulatory Science and Innovation to advance medical product development.

The high price of immunotherapies and other specialized cancer drugs threatens the financial sustainability of cancer treatment, according to researchers from the Institute of Cancer Research in London and the University of Texas MD Anderson Cancer Center in Houston.

Here are six articles published by Becker's Hospital Review in the past week that reveal what President Trump and drug comapny CEOs talked about during their closed-door meeting, why UPS drivers don't turn left and more.

Margaret Chan, director of the World Health Organization, on Wednesday warned against deregulating the Food and Drug Administration while speaking at a conference at the University of Washington in Seattle, reports STAT.

The Pharmaceutical Care Management Association, a major lobby group for pharmacy benefit manufacturers, released a video about a heavily discussed topic: price transparency.

Here are four drugs and medical devices approved by the Food and Drug Administration this week.